Companies in #Glioblastoma

Clinical-stage Chinese biotech developing CAR-T cell therapies for solid tumors and hematological malignancies.

Kopra Bio is a UCSF spinout and Y Combinator-backed biotech developing viral immunotherapies for cancer. Its proprietary InViTE (In Vivo Tumor Editing) platform uses genetically engineered viruses designed to selectively infect and destroy tumor cells, starting with glioblastoma.